A Study of Brenipatide in Participants With Alcohol Use Disorder

Summary

The purpose of this study is to see if brenipatide when compared to a placebo works and is safe for participants with Alcohol Use Disorder (AUD) and hazardous alcohol use. Participation in this study will last approximately 56 weeks.

Timeline

Start

2025-10-16

Primary completion

2028-04

Completion

2028-04

Drugs

Indications